Tumor necrosis factor- alpha synergizes with IFN- gamma in mediating killing of Leishmania major through the induction of nitric oxide.
Abstract
CBA mice develop cutaneous lesions when infected with Leishmania major. The disease development was significantly reduced by injecting into the lesion a combination of rIFN-gamma and rTNF-alpha. The doses of IFN-gamma and TNF-alpha used were suboptimal in that either cytokine alone did not have any effect. The therapeutic effect of IFN-gamma and TNF-alpha in vivo is reflected in their ability to activate macrophages to kill the intracellular parasites in vitro. The macrophage leishmanicidal activity induced by TNF-alpha and IFN-gamma can be completely inhibited by a specific inhibitor (l-NG monomethyl arginine) of nitric oxide synthesis. There was a direct correlation between the intracellular killing of the parasites and the production of nitric oxide by the macrophages. In contrast, there was no correlation between leishmanicidal activity and superoxide production by macrophages.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
IFNγ co-operates with other TH1 cell cytokines and acts synergistically to enhance their ability to eliminate pathogens.
“It is worth noting that IFNγ co-operates with other TH1 cell cytokines and acts synergistically to enhance their ability to eliminate pathogens31,32.”
From An Omicron-specific, self-amplifying mRNA booster vaccine for COVID-19: a phase 2/3 randomized trial (2024) · cites this paper as [32]
Cited by
Sorted by citations
Flynn, J., & Chan, J. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.93 · Cited by 1,144 · see citing works
Flynn, J. L., Goldstein, M. M., Chan, J., Triebold, K. J., Pfeffer, K., Lowenstein, C. J., Schrelber, R., Mak, T. W., & Bloom, B. R. (1995) · Immunity · doi:10.1016/1074-7613(95)90001-2 · Cited by 1,678 · see citing works
T-cell quality in memory and protection: implications for vaccine design
Seder, R. A., Darrah, P. A., & Roederer, M. (2008) · Nature reviews. Immunology · doi:10.1038/nri2274 · Cited by 1,541 · see citing works
Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major
Darrah, P. A., Patel, D. T., Luca, P. M. D., Lindsay, R. W. B., Davey, D. F., Flynn, B. J., Hoff, S. T., Andersen, P. L., Reed, S. G., Morris, S. L., et al. (2007) · Nature Medicine · doi:10.1038/nm1592 · Cited by 1,364 · see citing works
The Central Role of CD4+ T Cells in the Antitumor Immune Response
Hung, K., Hayashi, R., Lafond-Walker, A., Lowenstein, C., Pardoll, D., & Levitsky, H. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2357 · Cited by 1,345 · see citing works
The Molecular Cell Biology of Interferon-gamma and its Receptor
Farrar, M. A., & Schreiber, R. D. (1993) · Annual Review of Immunology · doi:10.1146/annurev.iy.11.040193.003035 · Cited by 1,345 · see citing works
Peroxynitrite formation from macrophage-derived nitric oxide
Ischiropoulos, H., Zhu, L., & Beckman, J. S. (1992) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(92)90433-w · Cited by 1,099 · see citing works
Hu, S., Marshall, C., Darby, J. M., Wei, W., Lyons, A. B., & Körner, H. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00001 · Cited by 982 · see citing works
“It could be shown that it activated macrophages and synergized with IFN-γ to induce effector functions (8, 37).”
BackgroundLyons, C., Orloff, G. J., & Cunningham, J. M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42704-4 · Cited by 866 · see citing works
Regulation of Immunity to Parasites by T Cells and T Cell-Derived Cytokines
Sher, A., & Coffman, R. L. (1992) · Annual Review of Immunology · doi:10.1146/annurev.iy.10.040192.002125 · Cited by 841 · see citing works
Farrell, A. J., Blake, D. R., Palmer, R. M. J., & Moncada, S. (1992) · Annals of the Rheumatic Diseases · doi:10.1136/ard.51.11.1219 · Cited by 717 · see citing works
Benjamin, N., O'Driscoll, F., Dougall, H., Duncan, C., Smith, L., Golden, M., & McKenzie, H. (1994) · Nature · doi:10.1038/368502a0 · Cited by 665 · see citing works
Lorsbach, R. B., Murphy, W. J., Lowenstein, C. J., Snyder, S. H., & Russell, S. W. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53940-5 · Cited by 619 · see citing works
Scharton, T. M., & Scott, P. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.178.2.567 · Cited by 613 · see citing works
Alspach, E., Lussier, D. M., & Schreiber, R. D. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028480 · Cited by 617 · see citing works
“Nitric oxide produced by macrophages downstream from IFN-γ signaling, in combination withNF-κB signaling, directly confers resistance against the growth of intracellular pathogens (Liew et al. 1990a,b).”
BackgroundLeishmaniasis: Current Status of Vaccine Development
Handman, E. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.2.229-243.2001 · Cited by 595 · see citing works
“Protective immunity depends on the induction of T cells producing Th1 cytokines which activate macrophages to kill the intracellular organisms primarily through a nitric oxide-mediated mechanism (74).”
BackgroundLeishmaniases of the New World: current concepts and implications for future research
Grimaldi, G., & Tesh, R. B. (1993) · Clinical Microbiology Reviews · doi:10.1128/cmr.6.3.230 · Cited by 570 · see citing works
Role of oxidants in microbial pathophysiology
Miller, R. A., & Britigan, B. E. (1997) · Clinical Microbiology Reviews · doi:10.1128/cmr.10.1.1 · Cited by 577 · see citing works
“By treating murine-activated macrophages in vitro with N-monomethyl-L-arginine, a competitive inhibitor of nitrate and nitrite synthesis from L-arginine, a number of investigators have implicated NO as having microbiostatic and/or microbicidal activity against pathogens such as Cryptococcus neoformans (117), Toxoplasm…”
BackgroundScharton‐Kersten, T., Yap, G. S., Magram, J., & Sher, A. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.7.1261 · Cited by 423 · see citing works
Up-Regulation of Th1-Type Responses in Mucosal Leishmaniasis Patients
Bacellar, O., Lessa, H. A., Schriefer, A., et al. (2002) · Infection and Immunity · doi:10.1128/iai.70.12.6734-6740.2002 · Cited by 385 · see citing works
“IFN- , TNF- , and NO are products that are necessary to kill leishmania (22), but they are also implicated in the inflammation leading to tissue damage (19, 32).”
BackgroundLeishmania species: models of intracellular parasitism
Alexander, J. K., Satoskar, A. R., & Russell, D. G. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.18.2993 · Cited by 348 · see citing works
The Importance of Th2 Cytokines in Protective Immunity to Nematodes
Urban, J. F., Madden, K. B., Svetica, A., Cheever, A. W., Trotta, P. P., Gause, W. C., Katona, I. M., & Finkelman, F. D. (1992) · Immunological Reviews · doi:10.1111/j.1600-065x.1992.tb01415.x · Cited by 345 · see citing works
“C57BL/6 mice secrete IFN-y, which, together with TNF-a, activates macrophages to kill ingested amastigotes (Liew et al. 1990).”
BackgroundLiew, F. Y., & O’Donnell, C. A. (1993) · Advances in Parasitology/Advances in parasitology · doi:10.1016/s0065-308x(08)60208-0 · Cited by 334 · see citing works
Self-citationRole of nitric oxide in parasitic infections
James, S. L. (1995) · Microbiological Reviews · doi:10.1128/mr.59.4.533-547.1995 · Cited by 357 · see citing works
The Interaction of Leishmania Species with Macrophages
Alexander, J. K., & Russell, D. G. (1992) · Advances in Parasitology/Advances in parasitology · doi:10.1016/s0065-308x(08)60022-6 · Cited by 323 · see citing works
Immunology of tuberculosis and implications in vaccine development
Flynn, J. L. (2003) · Tuberculosis · doi:10.1016/j.tube.2003.08.010 · Cited by 304 · see citing works
Stenger, S., Thüring, H., Röllinghoff, M., & Bogdan, C. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.180.3.783 · Cited by 302 · see citing works
Melby, P. C., Chandrasekar, B., Zhao, W., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.3.1912 · Cited by 289 · see citing works
Nauciel, C., & Espinasse-Maes, F. (1992) · Infection and Immunity · doi:10.1128/iai.60.2.450-454.1992 · Cited by 283 · see citing works
“A synergistic interaction between IFN--y and TNF-a has been reported in several other studies (14, 22, 26).”
ResultFlesch, I. E. A., & Kaufmann, S. H. E. (1991) · Infection and Immunity · doi:10.1128/iai.59.9.3213-3218.1991 · Cited by 280 · see citing works
Oxidative Responses of Human and Murine Macrophages During Phagocytosis of Leishmania chagasi
Gantt, K. R., Goldman, T. L., McCormick, M. L., Miller, M. A., Jerônimo, S. M. B., Nascimento, E. T., Britigan, B. E., & Wilson, M. E. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.2.893 · Cited by 278 · see citing works
Parasitic Adaptive Mechanisms in Infection by Leishmania
Cunningham, A. C. (2002) · Experimental and Molecular Pathology · doi:10.1006/exmp.2002.2418 · Cited by 267 · see citing works
Mackowiak, P. A. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.17.1870 · Cited by 254 · see citing works
Szabó, C., Zingarelli, B., & Salzman, A. L. (1996) · Circulation Research · doi:10.1161/01.res.78.6.1051 · Cited by 247 · see citing works
Basu, R., Bhaumik, S., Basu, J. M., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.11.7160 · Cited by 244 · see citing works
Liew, F. Y., Li, Y., Severn, A., Millott, S. M., Schmidt, J., Salter, M., & Moncada, S. (1991) · European Journal of Immunology · doi:10.1002/eji.1830211027 · Cited by 222 · see citing works
Self-citationEffects of cytokines on intracellular growth of Brucella abortus
Jiang, X., & Baldwin, C. L. (1993) · Infection and Immunity · doi:10.1128/iai.61.1.124-134.1993 · Cited by 224 · see citing works
Pro- and anti-inflammatory cytokines in cutaneous leishmaniasis: a review
Maspi, N., Abdoli, A., & Ghaffarifar, F. (2016) · Pathogens and Global Health · doi:10.1080/20477724.2016.1232042 · Cited by 225 · see citing works
Cytokine profile and pathology in human leishmaniasis
Ribeiro-de-Jesus, A., de Almeida, R. P., Lessa, H. A., et al. (1998) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x1998000100020 · Cited by 219 · see citing works
Inducible nitric oxide synthase activity of cloned murine microglial cells
Corradin, S. B., Mauël, J., Donini, S. D., Quattrocchi, E., & Ricciardi‐Castagnoli, P. (1993) · Glia · doi:10.1002/glia.440070309 · Cited by 216 · see citing works
The arginine‐nitric oxide pathway: A target for new drugs
Kerwin, J. F., & Heller, M. (1994) · Medicinal Research Reviews · doi:10.1002/med.2610140103 · Cited by 204 · see citing works
Liew, F. Y., Li, Y., Moss, D., Parkinson, C., Rogers, M. V., & Moncada, S. (1991) · European Journal of Immunology · doi:10.1002/eji.1830211216 · Cited by 197 · see citing works
Self-citationCunha, F. Q., Assreuy, J., Moss, D. W., Rees, D. D., Leal, L. M. C. C., Moncada, S., CARRIER, M. J., O'Donnell, C. A., & Liew, F. Y. (1994) · PubMed Central · Cited by 192 · see citing works
Self-citationRapidly Fatal Leishmaniasis in Resistant C57BL/6 Mice Lacking TNF
Wilhelm, P., Ritter, U., Labbow, S., Donhauser, N., Röllinghoff, M., Bogdan, C., & Körner, H. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.6.4012 · Cited by 184 · see citing works
de Faria, D. R., Gollob, K. J., Barbosa, J., et al. (2005) · Infection and Immunity · doi:10.1128/iai.73.12.7853-7859.2005 · Cited by 186 · see citing works
Polyfunctional CD4+ T Cells As Targets for Tuberculosis Vaccination
Lewinsohn, D. A., Lewinsohn, D. M., & Scriba, T. J. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01262 · Cited by 176 · see citing works
“major infection (19, 20), which in turn is associated with enhanced control of disease by the combination of IFN-γ and TNF-α in the murine model (20).”
BackgroundCarneiro, P. P., Conceição, J., Macedo, M. N., Magalhães, V., Carvalho, E. M., & Bacellar, O. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148084 · Cited by 179 · see citing works
“In murine systems, IFN-γ has been shown to synergize with TNF, to activate inducible nitric oxide synthase (iNOS or NOS2) to produce nitric oxide (NO) resulting in eradication of intracellular parasites [11, 12].”
BackgroundPeroxynitrite: A two-faced metabolite of nitric oxide
Muijsers, R. B. R., Folkerts, G., Henricks, P. A. J., Sadeghi-Hashjin, G., & Nijkamp, F. P. (1997) · Life Sciences · doi:10.1016/s0024-3205(96)00651-0 · Cited by 176 · see citing works
Chan, E. D., Morris, K. R., Belisle, J. T., Hill, P. J., Remigio, L. K., Brennan, P. J., & Riches, D. W. H. (2001) · Infection and Immunity · doi:10.1128/iai.69.4.2001-2010.2001 · Cited by 171 · see citing works
Dieterich, D. T., Lew, E. A., Kotler, D. P., Poles, M. A., & Orenstein, J. M. (1994) · Journal of Infectious Diseases · doi:10.1093/infdis/169.1.178 · Cited by 170 · see citing works
The Role of Nitric Oxide in Inflammation
Lyons, C. R. (1995) · Advances in immunology · doi:10.1016/s0065-2776(08)60589-1 · Cited by 169 · see citing works
Pine, R. I. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.21.4346 · Cited by 164 · see citing works
Allendoerfer, R., & Deepe, G. S. (1998) · PubMed · Cited by 164 · see citing works
Coler, R. N., Duthie, M. S., Hofmeyer, K. A., Guderian, J., Jayashankar, L., Vergara, J., Rolf, T., Misquith, A., Laurance, J. D., Raman, V. S., et al. (2015) · Clinical & Translational Immunology · doi:10.1038/cti.2015.6 · Cited by 163 · see citing works
Saio, M., Radoja, S., Marino, M., & Frey, A. B. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.10.5583 · Cited by 157 · see citing works
Allendoerfer, R., & Deepe, G. S. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.12.6072 · Cited by 156 · see citing works
Rodeberg, D. A., Chaet, M. S., Bass, R. C., Arkovitz, M. S., & Garcia, V. F. (1995) · The American Journal of Surgery · doi:10.1016/s0002-9610(05)80017-0 · Cited by 154 · see citing works
Ferlita, S., Yegiazaryan, A., Noori, N., Lal, G., Nguyen, T. K., To, K., & Venketaraman, V. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8122219 · Cited by 151 · see citing works
“TNF-α also works in synergy with IFN-γ to induce nitric oxide production [33].”
Backgroundde Faria, D. R., Souza, P. E. A., Durães, F. V., Carvalho, E. M., Gollob, K. J., Machado, P. R. L., & Dutra, W. O. (2009) · Parasite Immunology · doi:10.1111/j.1365-3024.2009.01125.x · Cited by 142 · see citing works
Evaluation of Immunomodulatory Effects of Lactic Acid Bacteria in Turbot (Scophthalmus maximus)
Villamil, L., Tafalla, C., Figueras, A. J., & Novoa, B. (2002) · Clinical and Vaccine Immunology · doi:10.1128/cdli.9.6.1318-1323.2002 · Cited by 142 · see citing works
Chan, E. D., Winston, B. W., Uh, S., Wynes, M. W., Rose, D. M., & Riches, D. W. H. (1999) · PubMed · Cited by 139 · see citing works
Roach, T. I. A., Kiderlen, A. F., & Blackwell, J. M. (1991) · Infection and Immunity · doi:10.1128/iai.59.11.3935-3944.1991 · Cited by 138 · see citing works
Schleicher, U., Paduch, K., Debus, A., Obermeyer, S., König, T., Kling, J. C., Ribechini, E., Dudziak, D., Mougiakakos, D., Murray, P. J., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.04.001 · Cited by 136 · see citing works
“…1 T helper (Th1) cells and the expression of NOS2, which are strictly required for the resolution of Leishmania infections (Diefenbach et al., 1998; Liew et al., 1990), were preserved in Tnf / mice (Wilhelm et al., 2001), leading to interest in identifying the mechanism that underlies the…”
Hbsag Retention Sensitizes the Hepatocyte to Injury by Physiological Concentrations of Interferon–γ
Gilles, P. N., Guerrette, D. L., Ulevitch, R. J., Schreiber, R. D., & Chisari, F. V. (1992) · Hepatology · doi:10.1002/hep.1840160308 · Cited by 133 · see citing works
Immune privilege in sites of chronic infection: Leishmania and regulatory T cells
Peters, N. C., & Sacks, D. L. (2006) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00432.x · Cited by 132 · see citing works
Bengtsson, K. L., Song, H., Stertman, L., et al. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.02.033 · Cited by 131 · see citing works
Sato, H., Fujiwara, K., Sagara, J., & Bannai, S. (1995) · Biochemical Journal · doi:10.1042/bj3100547 · Cited by 128 · see citing works
Chen, E. S., Greenlee, B. M., Wills-Karp, M. A., & Möller, D. R. (2001) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.24.5.4064 · Cited by 125 · see citing works
Naotunne, T. D. S., Karunaweera, N. D., Mendis, K., & Carter, R. (1993) · PubMed Central · Cited by 125 · see citing works
Chan, E. D., Winston, B. W., Uh, S., Wynes, M. W., Rose, D. M., & Riches, D. W. H. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.1.415 · Cited by 125 · see citing works
Das, L., Datta, N., Bandyopadhyay, S. K., & Das, P. K. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.6.4020 · Cited by 123 · see citing works
Tumor Necrosis Factor and Lymphotoxin
Beyaert, R., & Fiers, W. (1998) · Elsevier eBooks · doi:10.1016/b978-012498340-3/50025-7 · Cited by 119 · see citing works
Li, J., Hunter, C. A., & Farrell, J. P. (1999) · PubMed · Cited by 120 · see citing works
Gross, A., Spiesser, S., Terraza, A., Rouot, B., Caron, E., & Dornand, J. (1998) · Infection and Immunity · doi:10.1128/iai.66.4.1309-1316.1998 · Cited by 119 · see citing works
Bogdan, C. (2020) · Cytokine X · doi:10.1016/j.cytox.2020.100041 · Cited by 113 · see citing works
Bermudez, L. E. (1993) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1993.tb05895.x · Cited by 118 · see citing works
Low dose TGF-beta attenuates IL-12 responsiveness in murine Th cells.
Gorham, J. D., Guler, M. L., Fenoglio, D., Gubler, U., & MURPHY, K. M. M. (1998) · PubMed · Cited by 116 · see citing works
Taylor, G. A., Jeffers, M., Largaespada, D. A., Jenkins, N. A., Copeland, N. G., & Woude, G. F. V. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.34.20399 · Cited by 116 · see citing works
Th1 CD4+ lymphocytes delete activated macrophages through the Fas/APO-1 antigen pathway.
Ashany, D., Song, X., Lacy, E., et al. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.24.11225 · Cited by 115 · see citing works
MacFarlane, A. S., Schwacha, M. G., & Eisenstein, T. K. (1999) · Infection and Immunity · doi:10.1128/iai.67.2.891-898.1999 · Cited by 114 · see citing works
Green, S. J., Nacy, C. A., Schreiber, R. D., Granger, D. L., Crawford, R. M., Meltzer, M. S., & Fortier, A. H. (1993) · Infection and Immunity · doi:10.1128/iai.61.2.689-698.1993 · Cited by 109 · see citing works
Silvestre, R., Cordeiro‐da‐Silva, A., Santarém, N., Vergnes, B., Séréno, D., & Ouaissi, A. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.5.3161 · Cited by 110 · see citing works
Visceral Leishmaniasis in Mice Devoid of Tumor Necrosis Factor and Response to Treatment
Murray, H. W., Jungbluth, A., Ritter, E., et al. (2000) · Infection and Immunity · doi:10.1128/iai.68.11.6289-6293.2000 · Cited by 110 · see citing works
The role of protein kinase C in the induction of nitric oxide synthesis by murine macrophages
Severn, A., Wakelam, M. J. O., & Liew, F. Y. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)91330-s · Cited by 109 · see citing works
Self-citationVázquez‐Torres, A., Fantuzzi, G., Edwards, C. K., Dinarello, C. A., & Fang, F. C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041618998 · Cited by 107 · see citing works
Theodos, C. M., & Titus, R. G. (1993) · Parasite Immunology · doi:10.1111/j.1365-3024.1993.tb00634.x · Cited by 108 · see citing works
Collective nitric oxide production provides tissue-wide immunity during Leishmania infection
Olekhnovitch, R., Ryffel, B., Müller, A. J., & Bousso, P. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72058 · Cited by 102 · see citing works
Yu, H. B., Jiang, X., Shen, C., Karunakaran, K. P., Jiang, J., Rosin, N. L., & Brunham, R. C. (2010) · Infection and Immunity · doi:10.1128/iai.01374-09 · Cited by 100 · see citing works
“TNF is another effector cytokine produced by Th1 cells that can mediate control of intracellular infection, including that due to Chlamydia (23, 30, 35).”
BackgroundParamchuk, W. J., Ismail, S. O., Bhatia, A., & Gedamu, L. (1997) · Molecular and Biochemical Parasitology · doi:10.1016/s0166-6851(97)00141-2 · Cited by 100 · see citing works
Chen, L., & Mehta, J. L. (1996) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199601000-00024 · Cited by 100 · see citing works
Li, J., Hunter, C. A., & Farrell, J. P. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.2.974 · Cited by 99 · see citing works
Morris, K. R., Lutz, R. D., Choi, H.-S., Kamitani, T., Chmura, K., & Chan, E. D. (2003) · Infection and Immunity · doi:10.1128/iai.71.3.1442-1452.2003 · Cited by 98 · see citing works
Role of nitric oxide in Sjögren's syndrome
Konttinen, Y. T., Platts, L. A. M., Tuominen, S., Eklund, K. K., Santavirta, N., Törnwall, J., Sorsa, T. A., Hukkanen, M., & Polak, J. M. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400515 · Cited by 98 · see citing works
Low Dose TGF-β Attenuates IL-12 Responsiveness in Murine Th Cells
Gorham, J. D., Guler, M. L., Fenoglio, D., Gubler, U., & MURPHY, K. M. M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.4.1664 · Cited by 98 · see citing works
Analgesic and anti-inflammatory effects ofMangifera indica L. extract (Vimang)
Garrido, G., Gonz�lez, D., Delporte, C. L., Backhouse, N., Quintero, G., Sellés, A. J. N., & Morales, M. A. (2001) · Phytotherapy Research · doi:10.1002/1099-1573(200102)15:1 · Cited by 167 · see citing works
Cytokines: Making the right choice
Finkelman, F. D., & Urban, J. F. (1992) · Parasitology Today · doi:10.1016/0169-4758(92)90105-b · Cited by 97 · see citing works
Torrado, E., Adusumilli, S., Fraga, A. G., Small, P. L. C., Castro, A. G., & Pedrosa, J. (2007) · Infection and Immunity · doi:10.1128/iai.00290-07 · Cited by 95 · see citing works
“From studies in the mouse model, it is known that TNF is required to upregulate the macrophage bactericidal mechanisms, particularly in concert with IFN- (7, 24, 52).”
BackgroundLin, J., Seguin, R. M., Keller, K., et al. (1994) · Infection and Immunity · doi:10.1128/iai.62.5.1534-1541.1994 · Cited by 95 · see citing works
“vated macrophages, has been shown to be a potent mediator of the immune response against parasitic infection (15), such as those caused by Plasmodium yoelii (30), Leishmania major (18-20, 31), Toxoplasma gondii (2), Trypanosoma cruzi (33), and Schistosoma mansoni (16).”
BackgroundTargeted Delivery of IFNγ to Tumor Vessels Uncouples Antitumor from Counterregulatory Mechanisms
Curnis, F., Gasparri, A. M., Sacchi, A., Cattaneo, A., Magni, F., & Corti, A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4282 · Cited by 94 · see citing works
Ohkusu, K., Yoshimoto, T., Takeda, K., et al. (2000) · Infection and Immunity · doi:10.1128/iai.68.5.2449-2456.2000 · Cited by 94 · see citing works
- Authors
- Liew, F. Y., Li, Y., & Millott, S.
- Affiliations
- Wellcome Trust (GB)
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1990-12
- Volume
- 145
- Issue
- 12
- Pages
- 4306-4310
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1739247159
- Cited by
- 522
- References
- 0
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 5 · 2023: 9 · 2022: 10 · 2021: 9 · 2020: 16 · 2019: 7 · 2018: 14 · 2017: 16 · 2016: 11 · 2015: 13 · 2014: 21 · 2013: 16 · 2012: 15
- FWCI
- 37.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Research on Leishmaniasis Studies
- Health Sciences › Medicine › Infectious Diseases › Leprosy Research and Treatment
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- Leishmania major, cutaneous leishmaniasis, TNF-α, interferon-gamma, nitric oxide, macrophage activation, antileishmanial activity, L-NG-monomethylarginine, superoxide, cytokine synergy
- MeSH terms
- Animals, Arginine, Cytotoxicity, Immunologic, Drug Synergism, Hydrogen Peroxide, Immunity, Cellular, Interferon-gamma, Leishmania tropica, Leishmaniasis, Macrophages, Mice, Inbred CBA, Nitric Oxide, Nitrites, Superoxides, Tumor Necrosis Factor-alpha, omega-N-Methylarginine, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review